Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.61 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 4/20 | 0.55 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.52 |
| ▸ | RAD52 | P43351 | 1/20 | 0.52 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 6/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | FAAH | O00519 | 1/20 | 0.50 |
| ▸ | DGKA | P23743 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10621483 | 1.00 | NAAA (0.61) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL335168 | 1.00 | NAAA (0.61) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL1206999 | 1.00 | NAAA (0.61) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL7129437 | 1.00 | NAAA (0.61) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL5836729 | 1.00 | NAAA (0.61) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL6739583 | 1.00 | NAAA (0.61) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL11131653 | 1.00 | NAAA (0.61) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL6740298 | 1.00 | NAAA (0.61) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL11132543 | 1.00 | NAAA (0.61) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL184446 | 1.00 | NAAA (0.61) | NAAAEPHX1TSHRHCAR2RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4635941-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | Nouryon Chemicals International B.V. (NL) | 2025-10-22 | — | — | EP | claimed |
| EP-4471010-B1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | NOURYON CHEMICALS INT BV (NL) | 2025-06-04 | — | — | EP | claimed |
| CN-119804738-A | Detection method for genotoxic impurities in dabigatran etexilate mesylate | 核工业北京化工冶金研究院 | 2025-04-11 | — | — | CN | claimed |
| CN-119735526-A | Preparation method of amidine intermediate of dabigatran etexilate | 江苏阿尔法集团盛基药业(宿迁)有限公司 | 2025-04-01 | — | — | CN | claimed |
| CN-113968840-B | High-purity dabigatran etexilate, and preparation method and application thereof | 北京四环制药有限公司 | 2025-03-25 | — | — | CN | claimed |
| US-20250069164-A1 | ENVIRONMENTAL ATTRIBUTES FOR CHEMICAL COMPOUNDS COMPRISING A CARBONYL GROUP | BASF SE (DE) | 2025-02-27 | — | — | US | claimed |
| CN-119504882-A | Synthesis method of GalNAc derivative | 北京炫景瑞医药科技有限公司 | 2025-02-25 | — | — | CN | claimed |
| US-20240400490-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2024-12-05 | — | — | US | claimed |
| EP-4471010-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | Nouryon Chemicals International B.V. (NL) | 2024-12-04 | — | — | EP | claimed |
| CN-119059951-A | Process for preparing peroxyesters or peroxycarbonates | 诺力昂化学品国际有限公司 | 2024-12-03 | — | — | CN | claimed |
| EP-2262771-A1 | A METHOD FOR THE PREPARATION OF DABIGATRAN | Zentiva, K.S. (CZ) | 2010-12-22 | — | — | EP | claimed |
| WO-2010045900-A1 | A METHOD FOR THE PREPARATION OF DABIGATRAN AND ITS INTERMEDIATES | ZENTIVA, K.S. (CZ) | 2010-04-29 | — | — | WO | claimed |
| WO-2009111997-A1 | A METHOD FOR THE PREPARATION OF DABIGATRAN | ZENTIVA, K.S. (CZ) | 2009-09-17 | — | — | WO | claimed |
| US-20030139470-A1 | 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants | HAARMANN & REIMER GMBH (DE) | 2003-07-24 | — | — | US | claimed |
| EP-0402339-B1 | Improved process for the production of carbonate esters | MONSANTO CO (US) | 1994-10-05 | — | — | EP | claimed |
| EP-0414655-B1 | Improved process for the production of carbonate esters | MONSANTO CO (US) | 1993-10-20 | — | — | EP | claimed |
| US-5252770-A | Process for the production of carbonate esters | MONSANTO COMPANY (US) | 1993-10-12 | — | — | US | claimed |
| US-5183918-A | PROCESS FOR THE PRODUCTION OF CARBONATE ESTERS | MONSANTO COMPANY (US) | 1993-02-02 | — | — | US | claimed |
| EP-0414655-A1 | Improved process for the production of carbonate esters | MONSANTO COMPANY (US) | 1991-02-27 | — | — | EP | claimed |
| EP-0402339-A1 | Improved process for the production of carbonate esters | MONSANTO COMPANY (US) | 1990-12-12 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400490-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | GPX4, PRDX4, PRDX2 | NAAA 1037/4885EPHX1 360/4885TSHR 2104/4885 |
| US-20030139470-A1 | 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants | TYR, HAAO, TH | NAAA 2986/4885EPHX1 1805/4885TSHR 4451/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.